Loading organizations...
Co-win Ventures functions as a specialized venture capital firm, strategically investing in early and growth-stage companies. The firm demonstrates deep sector expertise, primarily targeting the TMT (Technology, Media, and Telecommunications) and Healthcare industries. Its investment approach includes high-tech areas like semiconductors, industrial software, and artificial intelligence, alongside innovative drug development.
Established in 2009, Co-win Ventures was founded by Ben Zhao, who serves as Founding and Managing Partner, with Xin Huang also holding a Managing Partner position. The firm’s genesis stemmed from the insight that profound professional knowledge, extensive industry experience, and an international perspective are crucial for fostering high-potential enterprises.
Co-win Ventures partners with promising companies, providing capital and strategic support for scaling. The firm's vision involves cultivating innovation and accelerating development within its specialized domains. Leveraging its team’s acute market understanding, Co-win Ventures aims to nurture future leaders in technology and life sciences, driving sustained growth.
Key people at Co-win Ventures.
Co-win Ventures has 16 tracked investments across 14 companies. The latest tracked deal is $22.0M Series C in Arima Genomics in June 2025.
Key people at Co-win Ventures.